Using machine learning methods to investigate the role of volatile organic compounds in non-alcoholic fatty liver disease
Using machine learning methods to investigate the role of volatile organic compounds in non-alcoholic fatty liver disease is a paper indexed in PICO Portal from OpenAlex.
How many citations does Using machine learning methods to investigate the role of volatile organic compounds in non-alcoholic fatty liver disease have?
Using machine learning methods to investigate the role of volatile organic compounds in non-alcoholic fatty liver disease has 4 citations in the OpenAlex counts PICO Portal stores.
When was Using machine learning methods to investigate the role of volatile organic compounds in non-alcoholic fatty liver disease published?
Using machine learning methods to investigate the role of volatile organic compounds in non-alcoholic fatty liver disease has 2025 year in the PICO Portal index.
What is the open-access status of Using machine learning methods to investigate the role of volatile organic compounds in non-alcoholic fatty liver disease?
Using machine learning methods to investigate the role of volatile organic compounds in non-alcoholic fatty liver disease has gold oa status in the PICO Portal index.
What is the DOI of Using machine learning methods to investigate the role of volatile organic compounds in non-alcoholic fatty liver disease?
The DOI for Using machine learning methods to investigate the role of volatile organic compounds in non-alcoholic fatty liver disease is on the source record.
What is the PMID of Using machine learning methods to investigate the role of volatile organic compounds in non-alcoholic fatty liver disease?
The PMID for Using machine learning methods to investigate the role of volatile organic compounds in non-alcoholic fatty liver disease is on the source record.
What is the OpenAlex record for Using machine learning methods to investigate the role of volatile organic compounds in non-alcoholic fatty liver disease?
The OpenAlex for Using machine learning methods to investigate the role of volatile organic compounds in non-alcoholic fatty liver disease is on the source record.